NCT07588178

Brief Summary

This study is titled "Metabolomics and Biomarker Research on the Mechanism of Preoperative Sleep Disorders Affecting Postoperative Outcomes in Adult Cardiac Surgery". It aims to clarify the perioperative metabolic changes caused by preoperative sleep disorders in adult cardiac surgery patients, providing ideas for exploring the mechanism by which sleep disorders affect adverse outcomes after cardiac surgery. The study will be conducted at Fuwai Hospital, Chinese Academy of Medical Sciences. By collecting perioperative blood and fecal samples from adult cardiac surgery patients with and without preoperative sleep disorders, and simultaneously recording postoperative clinical outcome indicators (such as the incidence of delirium within 7 days after surgery, cognitive function scores, mechanical ventilation time, ICU stay time, hospital stay time, and severe cardiovascular adverse events), the study will explore the impact of preoperative sleep disorders on perioperative plasma metabolic substances, inflammatory levels, nerve damage, oxidative stress levels, and intestinal flora in adult cardiac surgery patients under general anesthesia, providing ideas and evidence for exploring the mechanism by which preoperative sleep disorders affect postoperative outcomes in adult cardiac surgery patients under general anesthesia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Jan 2026Dec 2026

Study Start

First participant enrolled

January 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 14, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

12 months

First QC Date

May 8, 2026

Last Update Submit

May 8, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Differential changes in plasma metabolic substances during the perioperative period

    24 hours before and after the operation

Secondary Outcomes (4)

  • Perioperative inflammatory marker levels

    24 hours before and after the surgery

  • Perioperative nerve injury marker levels

    24 hours before and after the surgery

  • Perioperative oxidative stress marker levels

    24 hours before and after the surgery

  • Characteristics of the intestinal flora before the surgery

    24 hours before the surgery

Study Arms (1)

Adult patients scheduled for elective cardiac surgery

Other: This is a observational study and there is no intervention.

Interventions

This is a observational study and there is no intervention.

Adult patients scheduled for elective cardiac surgery

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients scheduled for elective cardiac surgery

You may qualify if:

  • Age ≥ 18 years
  • Scheduled for elective cardiac surgery

You may not qualify if:

  • Has a history of neurosurgery, or has suffered from neurological diseases such as cerebral hemorrhage, cerebral infarction, delirium, dementia, etc.
  • Has a history of mental disorders.
  • Heavy alcohol consumption.
  • American Society of Anesthesiologists (ASA) classification level IV or above.
  • Complicated with severe liver dysfunction (Child-Pugh C grade) or renal dysfunction (chronic kidney disease stage 3-4).
  • Unable to communicate due to hearing or language problems, or refuses to sign the informed consent form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai Hospital

Beijing, Beijing Municipality, 100037, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma, fecal sample

MeSH Terms

Conditions

Emergence DeliriumParasomnias

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental DisordersSleep Wake Disorders

Central Study Contacts

Fuxia Yan, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chinese Academy of Medical Sciences, Fuwai Hospital

Study Record Dates

First Submitted

May 8, 2026

First Posted

May 14, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 14, 2026

Record last verified: 2026-05

Locations